SurgOnc Today‪®‬ Society of Surgical Oncology

In this episode of SurgOnc Today, Brian Sparkman, MD, is joined by Lily Lai, MD, Margo Shoup, MD, MBA, and Kristen Massimino, MD, to discuss how CGSO fellowships prepare surgeons for a career in community practice and how we might improve this in the future.
Show Notes:
Medical students are caught in the residency 'research arms race' - STAT - https://www.statnews.com/2024/04/29/research-arms-race-medical-students-residency-applications/
Behrens S, Ann Surg Oncol. 2024 Jan; 31(1):31-42. DOI: 10.1245/s10434-023-14524-x
Clarke CN. Surg Oncol Clin N Am. 2022 Jan; 31910: 21 – 27. DOI: 10.1016/j.soc.2021.07.004
Wach MW. Ann Surg Oncol. 2019 Sep; 26(9):2675-2681. DOI: 10.1245/s10434-019-07372-1

In this episode of SurgOnc Today®, Sonia Orcutt, MD and Michail Mavros, MD, from the University of Arkansas for Medical Sciences are joined by Callisia N. Clarke, MD, MS, FACS, FSSO, Chief of the Division of Surgical Oncology at the Medical College of Wisconsin, and Alexandra Gangi, MD, FSSO, Director of the Gastrointestinal Tumor Program at Cedars Sinai Medical Center. The optimal treatment of high-grade well-differentiated neuroendocrine tumors has not been well-described, as they have only in recent years been identified as distinct from neuroendocrine carcinomas. The panelists discuss the most up-to-date information on diagnosis and management of gastroenteropancreatic high-grade well differentiated neuroendocrine tumors.

In this episode of SurgOnc Today, live from SSO 2024, Dr. Alex Parikh from the University of Texas – San Antonio and Chair of the SSO HPB disease site working group, and Dr. Julie Hallet from the University of Toronto, and Vice-Chair of the SSO HPB disease site working group, are joined by Dr. Ana Gleisner from the University of Colorado and Dr. Skye Mayo from the Oregon Health and Sciences University. They will be discussing two important aspects of the surgical management of perihilar cholangiocarcinoma: determining resectability as it relates to vascular involvement, and the role of neoadjuvant therapy.

In this episode of SurgOnc Today ®, Alex Parikh, MD, MPH, FACS, FSSO, from the University of Texas – San Antonio and Julie Hallet, MD, M.Sc., FRCSC, FSSO from the University of Toronto are joined by Monica M. Dua, MD, from Stanford University and Ching-Wei Tzeng, , MD, FACS, FSSO, from the MD Anderson Cancer Center. They will be discussing two important aspects of the surgical management of perihilar cholangiocarcinoma: strategies for pre-operative optimization and biliary drainage, and management of the future liver remnant. This is part one of a two-part series.

In this episode of SurgOnc Today®, Jennifer Plichta MD, Associate Professor of Surgery and Director of the Breast Risk Assessment Clinic at the Duke University Medical Center, is joined by Melissa Pilewskie, MD, Associate Professor of Surgery and Director of the Breast Care Center at the University of Michigan and Zahraa AlHilli, MD, MBA, Interim Director of the Breast Center and Co-Director of the Comprehensive Breast Program at Cleveland Clinic. Given the continuous advancements in breast imaging and risk assessment, it is important to be familiar with the latest imaging modalities, the risk assessment tools available, and how to incorporate them into routine clinical care. This episode focuses on the practical considerations for managing patients with an increased risk of breast cancer.

The management of locally advanced extremity soft tissue sarcomas require a multidisciplinary approach. Surgery remains the standard of care for cure, however, other loco-regional treatments including radiation and isolated limb perfusion as well as systemic treatments have been utilized to reduce local and distant recurrence risk. In this podcast, we will focus on the multidisciplinary approach for locally advanced extremity sarcomas. We will highlight the role of limb-sparing resections versus amputations.